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P-glycoprotein (P-gp) is a 170 kDa protein,
encoded by the human MDRI gene, which
has been shown to efflux a wide variety of
drugs such as the chemotherapeutic agents
doxorubicin, vincristine, and vinblastine
(1). P-gp in humans is located on the secre-
tory surfaces oforgans ofelimination, such
as the brush border of the renal proximal
tubules, the canalicular membrane ofhepa-
tocytes, and the apical surface of mucosal
cells in the small and large intestines (2).
This tissue localization and direct experi-
mental evidence (3) indicates that P-gp
plays a role in eliminating xenobiotics from
the whole organism. P-gp is also localized in
hormone-producing and hormone-respon-
sive organs such as the adrenal gland, the
testes, and the placenta (2). Steroid hor-
mones such as cortisol (4), corticosterone
(5), and aldosterone (6) have been shown to
be transport substrates for P-gp.
The involvement of P-gp in pesticide
toxicity was shown with the anthelmintic
agent ivermectin. Mdrla gene-knockout
mice treated with the neurotoxic pesticide
ivermectin demonstrated increased sensitivity
to this pesticide and increased accumulation
ofthis pesticide in the brain as compared to
control mice (7). When C57BL/6 mice were
cotreated with ivermectin and the P-gp
inhibitors SDZ PSC833 or SDZ 280-446,
the mice were hypersensitive to the neurotox-
ic effects of ivermectin compared to treat-
ment with ivermectin alone (8).
Additionally, rats treated with the pesticide
chlorpyrifos showed increased P-gp protein
levels in the bile duct, adrenal gland, stom-
ach, jejunum, and kidney proximal tubules
(9). Thus, P-gp appears to play a role in
both the efflux of chemicals from cells and
the elimination ofchemicals fromthe body.
Many compounds have been shown to
inhibit P-gp function, and the use of P-gp
inhibitors has received significant attention
as a possible means ofenhancing the effica-
cy of drugs transported by this protein by
decreasing their rate of efflux (10). Holfsli
and Nissen-Meyer (11) observed that 73%
of26 drugs assessed inhibited P-gp in vitro.
Studies in our laboratory have shown that
many pesticides can inhibit P-gp function
(12). Although the structures of P-gp
inhibitors differ significantly, common
characteristics include a molecular mass
greater than 300 (13,14) and lipophilicity
(11). Additional characteristics associated
with some P-gp inhibitors include amphi-
pathic properties (15) and a positive charge
at physiological pH (1,10,15). Molecular
characteristics of transport substrates of P-
gp are less well understood; however, P-gp
inhibitors have been typically assumed to
competitively inhibit transport substrates
(11,16), suggesting that inhibitory ligands
and transport substrates share similar mole-
cular characteristics.
In a previous study, we assessed the abil-
ity of38 pesticides to inhibit P-gp function
(12). Based upon these results, we conclud-
ed that chemicals with the greatest potential
to inhibit P-gp contained a cyclic structure
within the molecule, a molecular mass of
391-490 Da, and a log Kow of 3.6-4.5.
Seven ofthe inhibitory pesticides were eval-
uated for susceptibility to transport by P-
gp, but only one ofthe pesticides was trans-
ported by P-gp. These results demonstrated
that many pesticides are capable ofinhibit-
ing P-gp function; however, inhibition does
not imply that the pesticide is transported
by P-gp. Thus, transport substrates ofP-gp
may have significantly different molecular
characteristics than inhibitoryligands.
In the present study, we significantly
refined our structure-activity analysis of P-
gp inhibition by pesticides. In addition, the
structural attributes of P-gp inhibitors were
compared to those ofknown P-gp substrates
in order to define characteristics that dictate
whether a chemical will either inhibit or be
transported by P-gp. Six newpesticides were
then subjected to the structure-activity
analyses in order to predict the level ofinter-
action with P-gp; these predictions were
thenvalidated experimentally.
Materials and Methods
Structure-activity analyses. Molecular
attributes used in the structure-activity
analyses were calculated using Molecular
Modeling Pro software (NorGwyn
Montgomery Software, Inc., North Wales,
PA). Known P-gp transport substrates and
pesticides previously shown to inhibit P-gp
(12 were selected for analysis. In addition,
15 pesticides that had previously been
shown not to interact with P-gp (12 were
randomly selected to provide an approxi-
mately equal number of transport sub-
strates, inhibitory ligands, and noninteract-
ing compounds. These compounds were
analyzed for the following molecular
descriptors as described (with citations) in
the software manual:
Molecular weight was calculated as the
sum ofthe individualweights ofthe atoms
comprising the molecule (values are exact)
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* Surface area was calculated as the surface
area of spheres of Van der Waals radii
minus overlaps (values are accurate)
* Volume was calculated as the volume of
spheres of Van der Waals Radii minus
overlaps (values forvolume are accurate)
* Kappa shape represented Kier's index of
shape (values are exact)
* Connectivity 0,1,2,3 indices were derived
from Randic's graph theory. Values of
connectivity provide clues to the shape
and size ofmolecules (values are exact)
* Dipole moment was calculated using the
DelRe method of calculating partial
charge strength and location (dipole
moment values are affected by molecular
conformation but are reasonably accurate)
* Valence indices 0,1,2,3 provided mea-
sures of various electrostatic features of
the molecule (values are accurate)
* Percent hydrophilic surface was calculated
using an algorithm that determines which
components of the molecule are
hydrophilic. Hydrophiic surface was divid-
ed bytotal surface area (as defined above) x
100 (values are reasonably accurate)
* The hydrophilic-lipophilic balance was
obtained by dividing the molecular
weight of the water soluble portions of
the molecule by the total molecular
weight x 20 (values are accurate)
* Dispersion (Hansen 3-D parameter) mea-
suredthe repulsive forces between molecules
(values aremoderately toveryaccurate)
* The log KA, (log octanol:water partition
coefficient) was calculated by the modi-
fied Hansch fragment addition method.
Values are accurate for small ortanic mol-
ecules; accuracy decreases as molecular
mass and complexity increases
* Solubility was calculated as the square root
ofthe sumofsquares ofdispersion, polarity,
and H bonding (values arefairlyaccurate)
* Polarity (Hansen 3-D parameter) mea-
sured the localization ofpositive and neg-
ative charges associated with a molecule
(values are moderately to very accurate)
* Hydrogen bonding (Hansen 3-D para-
meter) measured the tendency ofa mole-
cule to form hydrogen bonds (accuracy
varies among molecules)
* Aromatic structures indicates the sum of
6-membered aromatic rings in the mole-
cule (values are exact)
* Total cyclic structures represents the sum
of closed chain (both aromatic and
nonaromatic) features (values are exact).
Compounds were grouped into three
classes: transport substrates, inhibitory lig-
ands, or noninteractors. For each molecu-
lar descriptor, means and standard devia-
tions were calculatedwithin each class, and
significant differences between classes was
evaluated by the Student's t-test.
Pesticides. Azinphos-ethyl, coumaphos,
fluazifop p-butyl, phosalone, and triforine
were purchased from Chem Service (West
Chester, PA). Dialifos was purchased from
Crescent Chemical Company (Hauppauge,
NY). All pesticides were at least 98% pure.
Cell lines. The parental murine
melanoma cell line B16/F1O was transfected
with the human MDRI gene by a replica-
tion-defective amphitrophic retrovirus togen-
erate the P-gp-overexpressing B16/hMDR1
cell line. The cells were cultured in RPMI
1640 medium supplemented with 10% fetal
bovine serum (Gibco BRL, Gaithersburg,
MD) at 37°C in a humidified atmosphere of
5% CO2/95% air. The expression ofP-gp, as
well as the characterization ofthe multixeno-
biotic resistance phenotype (MXR), in these
cells has been described previously (12,14).
The MXR phenotype of the B16/hMDR1
cells was maintained byintermittentlycultur-
ing the cells in 6 pM vinblastine (Sigma
Chemical Company, St. Louis, MO).
Transportofpesticides byP-glycoprotein.
B16/F10 and B16/hMDR1 cells were plated
in 35-mm petri dishes atadensityof0.8-1.0
X 106 cells/plate and were allowed to attach
overnight. The next morning, the medium
was aspirated offand replaced with medium
containing 100 pM ofthe pesticide ofinter-
est. Plates were incubated at 370C for 4 hr
after which the medium was removed and
the cells were washed twice with ice-cold
phosphate-buffered saline (PBS) and were
overlaid with fresh medium to allow for
efflux. After defined efflux periods, the medi-
um was aspirated off and the cells were
washed again with ice-cold PBS. The cells
were scraped into PBS and lysed by pulse
sonication, and the suspension was extracted
twice with ethyl acetate. Extraction efficien-
cies of the six pesticides were 81-98%. The
extract was evaporated under nitrogen and
the residue dissolved in HPLC mobile phase.
The amount of pesticide remaining in the
cells was detected by HPLC on aWaters LC
Module 1 Plus (Waters, Milford, MA)
equipped with a reverse-phase Nova-Pak C18
column (3.9 x 150 mm, 4 pm pore size).
The mobile phase for phosalone was 80%
methanol/20% water at 1 ml/min with
detection at 235 nm (17). The mobile phase
for coumaphos was 85% acetonitrile/15%
water at 2 ml/min with detection at 313 nm
(18). The mobile phase for azinphos-ethyl
was 80% methanol/20% water at 1 ml/min
with detection at 220 nm. The mobile phase
for dialifos was 67% acetonitrile/33% water
at 1.4 ml/min with detection at 225 nm.
The mobile phase for fluazifop p-butyl was
71% acetonitrile/29% water acidified to pH
3.0 with phosphoric acid at 1 ml/min and
detection at 270 nm (19). The mobile phase
for triforine was 80% methanol/20% water
at 1 ml/min with detection at 202 nm.
Results from three replicates per cell line are
presented for at least five time points during
the efflux period. Each data point represents
the percentage ofpesticide remaining in the
cells relative to the amount present in the
cells at the beginningoftheeffluxperiod.
The efflux oftwo known P-gp substrates,
doxorubicin and vincristine, were assessed in
the two cell lines as positive controls.
Doxorubicinwas incubatedwith the cells ata
concentration of50 pM. To extract the dox-
orubicin associated with the cells, they were
suspended in 1 ml PBS containing 100 pl of
0.1 M Trisbuffer, pH 8.4, andextracted into
5 ml chloroform. The mobile phase for dox-
orubicin consisted of 52% water/48% ace-
tonitrile, 10 mM SDS, 20 mM phosphoric
acid at a flow rate of 1.5 ml/min with detec-
tion at 233 nm (20). Cells were incubated in
7 pM vincristine andwere extracted from the
cells into 5 ml chloroform. The mobile phase
for vincristine detection was 60% acetoni-
trile/40% 25 mM phosphate buffer, pH 2.7,
adjusted with phosphoric acid, containing
0.25 g/l SDS at a flow rate of 0.9 ml/min
withdetection at238 nm (21).
Inhibition ofP-glycoprotein by pesti-
cides. B16/F10 and B16/hMDR1 cells
(0.2-1.0 x 106 cells/assay) were placed in
microfuge tubes containing 50 pM doxoru-
bicin (Pharmacia, Columbus, OH) in
RPMI 1640 medium and either various
concentrations of the pesticide or 10 pM
verapamil (Sigma), the positive control.
Cells were incubated at 370C for 4 hr before
being pelleted by centrifugation and washed
with ice-cold PBS. The pellet was resus-
pended and the cells washed again before
extraction solution (0.6 N HCl in 50%
water/50% ethanol) was added to each tube.
The pellet was then vortexed and the tubes
were refrigerated overnight. The amount of
doxorubicin associated with the cells was
measured fluorimetrically at 470 nm excita-
tion and 585 nm emission (22). The results
are presented for at least six concentrations
of pesticide using three replicates per cell
line. The effective concentration (EC50) of
the pesticide required to increase the level of
doxorubicin associated with the B16/
hMDR1 cells to half of that obtained with
cells containing 10 pM verapamil (maxi-
mum inhibition) was calculated by
Spearman-Karber regression analysis (23).
Results
Sture-activity analysis ofP-glycoprotein
transport substrates and inhibitory ligands.
Previous work in our laboratory has shown
that the optimal characteristics for a pesticide
to interact with P-gp are at least one cyclic
structure, amolecularweightof391-490 Da,
andalogK., 3.6-4.5. While thosecharacter-
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istics provide optimal binding to P-gp, only
one ofseven pesticides that show evidence of
binding to P-gp was actually transported by
this protein. Forty-four compounds were
analyzed in the present study, including 11
transport ligands, 18 inhibitors, and 15 non-
interactors (Table 1). Compounds were eval-
uated for various molecular attributes includ-
ing size/shape parameters (molecular weight,
surface area, volume, kappa shape, connectiv-
ity indices 0-3), electrostatic parameters
(dipole moment, valence indices 0-3), solu-
bility parameters (log K , solubiity, polarity,
percent hydrophilic surface, hydrophilic-
lipophiic balance), hydrogen bonding poten-
tial, cyclic components, and others (Table 2).
Predominant molecular characteristics
that significantly differ among the com-
Table 1. Compounds used in structure-activity
analyses
Class/compound Reference
pound classes are size/shape, with molecular
weight and cyclic structures being the most
informative attributes; solubility, with log
Ko being the most informative attribute;
hydrogen bonding potential; and electrostat-
ic parameters, with dipole moment being
most informative. Based upon these analyses,
criteriawere developed for the differentiation
of transport substrates, inhibitory ligands,
and noninteracting compounds using a two
tiered approach. The first tier was used to
differentiate transport substrates from
inhibitory ligands and noninteracting com-
pounds. Compounds were classified as trans-
port substrates ifthey met all of the follow-
ing tier 1 criteria: 1) the compound had at
least one .6-membered cyclic structure; 2)
the molecular weight was >399; 3) the log
K was <2; and 4) hydrogen bonding ow
potential was >8.
Remaining compounds were classified
as inhibitory ligands if they met all of the
following tier 2 criteria: 1) the compound
had at least one .6-membered cyclic struc-
ture; 2) the molecular weight was >247;
and 3) the dipole moment was .3.3.
Compounds that met neither the tier 1
nor tier 2 criteria were catagorized as non-
interacting compounds. Using these crite-
ria, transport substrates, inhibitory ligands,
and noninteracting compounds were
detected with 82%, 72%, and 89% accura-
cy, respectively.
In an attempt to validate these criteria, six
previously untested pesticides were subjected
to the two tier structure-activity analysis
(Table 3). None of the pesticides were pre-
dicted to be transport substrates based upon
molecular weight, log K , or hydrogen
bonding considerations. Coumaphos and
phosalone were predicted to be P-gp
inhibitors while azinphos-ethyl, dialifos, flu-
azifopp-butyl, and triforine were predicted to
be noninteractors. These catagorizations were
predicated by differences in dipole moments
ofthepesticides.
Transport substrate
Actinomycin D
Doxorubicin
Daunomycin
Vincristine
Vinblastine
Colchicine
Taxol
Endosulfan
Cyclosporin A
Etoposide
Hydroxyrubicin
Inhibitory ligand
Chlordecone
Verapamil
Nicardipine
Chlorthion
Phenamiphos
Tetrachlorohydroquinone
Parathion
Chlorpyrifos
Fluvalinate
Permethrin
Dicapthon
Heptachlor
Heptachlor epoxide
Diltiazim
Clomipramine
Hydramethylnon
Ivermectin
Clotrimazole
Noninteractor
Dieldrin
Mirex
Aldicarb
Phosmet
Methoxychlor
Aldoxycarb
Vinclozolin
Mevinphos
Lindane
Atrazine
Paraquat
Carbaryl
Aminocarb
Leptophos
Propiconazole
(1,10)
(1,10)
(1,10)
(1,10)
(1,10)
(1,10)
(1,10)
(14
(1,10)
(1,10)
(1,10)
(14
(24)
(24)
(14
(14
(14
(14
(14
(14
(14
(14
(14
(14
(24)
(24)
(14
(14
(14
(14
(14
(14
(14
(14
(14
(14
(14
(14
(14
(14
(14
(14
(14
(14
Table 2. Structure-activity relationships among noninteractors, inhibitors, and transport substrates of P-
glycoprotein
Noninteractors Inhibitors Transporters
Parameter (mean ± SD) Ratioa (mean ± SD) Ratio (mean ± SD) Ratio
Molecularweight 290.32 ± 102.49bc 1 407.88 ± 147.17cd 1.40 723.49 ± 295.59bd 2.49
Surface area 17.04 ±3.11bc 1 25.19 ± 12.23cd 1.48 49.61 ± 25.40bd 2.91
Volume 133.38 ±28.91b,c 1 199.36 ± 94.10c,d 1.49 388.97 ± 185.58bd 2.92
Kappa shape 5.35 ± 1.54bc 1 8.87 ± 5.18c,d 1.66 16.94 ± 10.55bd 3.12
Connectivity 0 23.88 ±4.43b,c 1 38.52 ± 25.84cd 1.61 83.86 ±47.16bd 3.51
Connectivity 1 7.78 ± 1.70bc 1 11.69 ±6.33cd 1.50 24.11 ± 10.37bd 3.10
Connectivity 2 7.48 ± 2.16bc 1 11.45 ± 5.37c,d 1.53 23.06 ±9.89bd 3.08
Connectivity3 6.40 ±3.06bc 1 9.61 ±4.76cd 1.50 20.36 ±7.83bd 3.19
Dipole moment 3.02 ± 1.68b,c 1 4.88 ± 2.54cd 1.61 7.94 ± 3.33b,d 2.63
Valence index0 22.64 ±3.78bc 1 35.96 ± 24.27cd 1.59 76.81 ±44.49b,d 3.39
Valence index 1 6.14 ± 1.94b,c 1 9.22 ±4.28c,d 1.50 17.48 ± 7.90bd 2.85
Valence index 2 5.52 ± 2.95c 1 7.75 ± 3.79c 1.40 14.85 ± 6.67bd 2.69
Valence index3 4.55±4.17c 1 6.11 ±3.84c 1.34 11.33±4.41bd 2.49
Percenthydrophilic surface 71.76± 21.11 1 61.96± 31.26 0.86 64.51 ± 16.83 0.90
Hydrophilic-lipophilic 16.04 ± 3.66 1 14.18 ± 5.63 0.88 15.79 ± 2.52 0.98
balance
Dispersion 20.01 ± 2.63 1 19.57 ± 4.64 0.98 19.42 ± 2.15 0.97
Log Kow 2.88 ± 2.70c 1 4.35 ± 1.94c 1.51 -0.34± 3.35b,d 0.12
Solubility 22.87 ± 2.80c 1 21.98 ± 5.09c 0.96 25.59 ± 3.35bd 1.12
Polarity 7.45 ± 2.59b 1 5.35 ± 2.55cd 0.72 8.00 ± 3.03b 1.07
Hydrogen bonding 7.18 ± 3.07c 1 7.73 ± 3.25c 1.08 14.04 ±3.98bd 1.96
Aromatic structures 1.00 ± 0.94c 1 1.29 ± 0.90c 1.29 1.55 ± 0.93b,d 1.55
Total cyclic structures 1.21 ±0.85bc 1 1.90 ± 1.18cd 1.57 4.27 ± 1.56bd 3.53
SD, standard deviation.
aRatios are the mean value forthat parameter divided bythe mean value forthe noninteractors.
bSignificantly differentfrom inhibitors bythe Student's t-test(p<0.05).
cSignificantly differentfrom transporters bythe Student's t-test(p<0.05).
dSignificantly differentfrom noninteractors bythe Student's t-test(p<0.05).
Table 3. Molecular parameters used in the structure-activity analyses of pesticides
Azinphos- Fluazifop
Parameter ethyl Coumaphos Dialifos p-butyl Phosalone Triforine
Molecularweight 345.38 362.77 393.85 383.38 367.81 434.96
Total cyclic structures 2 2 1 2 1 1
Log Kow 4.43 9.84 5.51 6.44 7.99 2.70
Hydrogen bonding 6.91 2.43 6.05 5.69 6.62 10.27
Dipole moment 1.47 7.67 3.29 2.65 4.91 0.70
Volume 105, Number8, August 1997 * Environmental Health Perspectives 814Articles - P-glycoprotein structure-activity relationships
Transport ofpesticides by P-glycoprotein.
The susceptibility of the six pesticides, in
addition to the known P-gp substrates dox-
orubicin and vincristine, to P-gp-mediated
transport then was determined experimen-
tally. B16/F1O and B16/hMDR1 cells were
incubated with each potential substrate for
4 hr; the cells were then washed and
allowed to efflux the accumulated com-
pound into clean medium. The amount of
potential substrate remaining in the cells at
various times during efflux was measured
by HPLC. The known P-gp substrates dox-
orubicin and vincristine were eliminated
from the P-gp-expressing B16/hMDR1
cells at a significantly greater rate than
from the parental B16/F10 cells (Figs. 1 A,
B). In contrast, the six pesticides were elim-
inated from both cell lines at comparable
rates (Figs. 1 C-H). Consistent with the
structure-activity predictions, the six pesti-
cides were not P-gp transport substrates.
Inhibition ofP-glycoprotein bypesticides.
The six pesticides were then evaluated exper-
imentally to identify inhibitors of P-gp.
Azinphos-ethyl, coumaphos, and phosalone
completely inhibited the P-gp-mediated
efflux of doxorubicin as indicated by the
increased accumulation of doxorubicin in
the B16/hMDR-1 cells (Fig. 2). EC50 values
were calculated to determine the relative
potency ofeach ofthese pesticides at inhibit-
ing the P-gp-mediated doxorubicin efflux
(Table 4). None of these pesticides were
nearly as potent as verapamil (EC50 = 3.2
11M), but were within the range ofEC50 val-
ues measured previously for pesticides (12.
Dialifos, fluazifop p-butyl, and triforine had
no effect on P-gp function at the highest
concentrations tested and were therefore
considered to be noninteracting compounds.
Structure-activity analyses accurately pre-
dicted the interactions offive ofthe six pesti-
cides (83%). Azinphos-ethyl was shown
experimentally to inhibit P-gp, but was pre-
dicted to be a noninteractor. Interestingly,
azinphos-ethyl was the least potent among
the three inhibitorypesticides.
Predictingpotency ofinhibitory ligands
towards P-glycoprotein. This and previous
studies (12) have shown that the potency
with which some xenobiotics inhibit P-gp
function varies widely. Therefore, relation-
ships among molecular characteristics and
potency of P-gp inhibitors were examined
using the inhibitors chlorpyrifos, 'clotrima-
zole, dicapthon, hydramethylnon, parathion,
and verapamil for which we had previously
measured EC50 values (12. Both molecular
surface area (r= 0.93) and volume (r= 0.97)
were highly correlated (p = 0.01) to EC50
values (Fig. 3). As either the surface area or
volume ofthe molecule increased, the poten-
cy of the pesticide to inhibit P-gp also
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Figure 1. Efflux of pesticides from B16 cells. B16/F10 cells and B16/hMDRI cells were incubated in (A) 50
pM doxorubicin; (B) 7 pM vincristine; (C) 100 pM phosalone; (D) 100 pM dialifos; (E) 100 pM azinphos-
ethyl; (F) 100 pM coumaphos; (G) 100 pM fluazifop p-butyl; and (H) 100 pM triforine for 4 hr and allowed to
depurate the accumulated pesticide (as described in Materials and Methods). The amount of pesticide
remaining in the cells was analyzed by HPLC and is presented as percentage ofthe initial concentration
of pesticide in the cells atthe start ofthe depuration phase. Values are the mean ± standard deviation of
three replicates for each time point.
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increased. Exponential linear regression
equations derived from these analyses were
EC50 = 8060 x 10-0.098(surface area) (1)
EC50 = 10937 x 10-O.013(volume) (2)
From these equations, the predicted EC50
values for each of the newly identified
inhibitory pesticides, azinphos-ethyl,
coumaphos, and phosalone were calculated
(Table 5). Both surface area and volume
accurately predicted the order ofpotency of
the pesticides and predicted the actual
EC50 values within a factor of2.
125 M 2 . _
100
75
50
25
0
125
100
-
0
0
C.
Discussion
P-gp is recognized primarily for its ability to
efflux a variety of structurally diverse anti-
cancer drugs from cells (25). P-gp may also
be important in the cellular clearance of
environmental chemicals, including some
pesticides and polycyclic aromatic hydrocar-
bons (12,26,27). Accordingly, this phase III
elimination process may prove to rival
phase I and II biotransformation processes
in the protection of organisms against
chemical toxicity. Considering the diversity
of compounds to which organisms are
exposed via food, water, and environment,
125 SOM
100
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50
25
0 50 lUU 150 ZU 25U 3UU
Azinphos-ethyl (jiM)
U 50 lUU 150 200 250 300
Coumaphos(gM)
an understanding ofthe structural attributes
that render a compound susceptible to
elimination by P-gp would greatly facilitate
the characterization of the role of P-gp in
protecting against toxicant insult.
Results from the present analyses indicate
that size, shape, solubility, and hydrogen-
bonding characteristics are all important
determinants ofchemical transport by P-gp.
Table 4. Inhibitory potency of pesticides towards
P-glycoprotein
Pesticide EC50a(Cl)
Azinphos-ethyl 129 (115-143)
Coumaphos 26.9(19.2-42.6)
Dialifos >250
Fluazifop p-butyl >250
Phosalone 96.4(88.3-98.9)
Triforine >250
Abbreviations: EC50, median effective concentra-
tion; Cl, 95% confidence interval.
aValues representthe concentration (pM) of each
compound that increased the accumulation of
doxorubicin in B16/hMDR1 cells to 50% of maxi-
mum as calculated by Spearman-Karber regres-
sion analysis. Results were derived from assays
of at least six concentrations of each compound
replicated threetimes.
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Figure 2. Inhibition of P-gp-mediated doxorubicin efflux by pesticides. B16/F10 cells and B16/hMDR1 cells
were incubated for 4 hr in 50 pM doxorubicin along with increasing concentrations of the pesticides. The
amount of doxorubicin accumulated in the cells was measured fluorimetrically and is presented as the
percentage of the amount of doxorubicin measured in the positive control cells incubated in 10 pM vera-
pamil. Values are the mean ± standard deviation ofthree replicates for each concentration of pesticide.
100 150 200
Volume (A3)
250 300
Figure 3. Correlation between P-gp inhibition
potency and molecular surface area (A) or vol-
ume (B) ofthe pesticides. Potency is described by
the effective concentration (EC50) values as previ-
ously determined (12). Molecular surface area
and volume of the pesticides are presented in
Table 2.
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Using the criteria defined in the tier 1 identi-
fication of P-gp transport substrates, the
steroids cortisol andaldosterone meet the cri-
teria for transport with respect to log K.,
and hydrogen-bonding potential, although
both compounds have molecular weights
that are slightly smaller than the 399 molec-
ular weight requirement. Progesterone, on
the other hand, is significantly smaller than
the other steroids and does not meet the
lipophilicity and hydrogen-bonding require-
ments for transport, and would be predicted
to be an inhibitor of P-gp according to the
tier 2 requirements. Cortisol and aldosterone
have been shown experimentally to be trans-
ported by P-gp, while progesterone is not a
transport substrate (6). Rather, progesterone
has been shown experimentally to be a
potent inhibitor of P-gp function (28).
These observations further support thevalid-
ity ofthe derived structure-activity relation-
ships and suggest that additional analyses
may reveal that compounds having a molec-
ular weight ofslightly less than 400 are also
transport candidates. Interestingly, 400 is
typically considered the approximate molec-
ular weight limit above which chemicals are
susceptible to biliary elimination (29).
Perhaps P-gp and related transporters located
on the canalicular membrane ofhepatocytes
areresponsible forthis size limitation.
The present study demonstrates that P-
gp transport substrates have higher molecu-
lar weights, lower log Ko, values, and
greater hydrogen-bonding potential than
compounds that are not transport sub-
strates. Further, the hydrogen-bonding
potential oftransport substrates is predomi-
nantly as hydrogen donors rather than
hydrogen acceptors (data not shown). All of
these characteristics are conferred to a mole-
cule as a result of hydroxylation.
Hydroxylation is a major biotransformation
process leading to the elimination of many
xenobiotics (29). Hydroxylation historically
has been considered to facilitate xenobiotic
elimination by increasing the aqueous solu-
bility ofthe compound and thus mobilizing
it in urine or bile. Present results suggest
that hydroxylation may actually target
xenobiotics for active elimination by P-gp.
The example of the steroid hormones pro-
vided above lends support to this hypothesis
in that both cortisol and aldosterone are
hydroxylated derivatives of progesterone
(30). Therefore, phase I hydroxylation
enzymes may function in concert with
phase III transport proteins to eliminate
toxic compounds from cells and from the
body. Precedents for similar interactions
between biotransformation enzymes and
active transport proteins exist. The mul-
tidrug resistance-associated protein (MRP)
and the organic anion transporter (MOAT)
are both involved in the cellular efflux of
compounds following glucuronic acid or
glutathione conjugation (31,32).
Transport substrates of P-gp tend to be
hydrophilic, based upon calculated log I§w
values, while inhibitory ligands were rela-
tively lipophilic. We noted previously that
lipophilicity increased the ability of pesti-
cides to inhibit P-gp up to a maximum
potency at a log KIw of 3.6-4.5 (12).
Inhibitory potency progressively decreased
as log Kow values of pesticides increased
beyond this optimum range. It is possible
that compounds having a log Kw ofgreater
than 4.5 are so highly partitioned into cell
membranes as to limit interaction with P-
gp. It is currently not clear whether the P-gp
inhibitors compete with transport substrates
for the same binding site. Should these com-
pounds interact at the same binding site, the
present data suggests that increasing
lipophilicity impedes transport while hydro-
gen bonding characteristics enhance trans-
portpotential.
Some inhibitors of P-gp had molecular
weights that were somewhat lower than the
minimum molecular weight of transport
substrates, though potency ofthe inhibitors
increased with increasing molecular volume
or surface area. Assuming that the inhibitors
competed for the same binding site as the
transport substrates, the data indicates that
compounds having a suboptimum molecu-
lar weight have the potential to bind to the
transport site; binding affinity increases with
increasing molecular mass, as indicated by
molecular surface area or volume, but trans-
port occurs only when a minimum molecu-
larweight requirement is met.
The susceptibility of P-gp to inhibition
by a variety of structurally diverse com-
pounds implicates this protein as a possible
target site of toxicity associated with many
environmental chemicals. For example, a
murine P-gp (mdr2 gene product) has been
implicated in the biliary elimination of
Table 5. Prediction of effective concentration (EC50) for P-glycoprotein inhibition values using volume and
surface area ofinhibitory pesticides
Predicted Surface Predicted Measured
Pesticide Volume (A3) EC50 (pM) area (A2) EC50(pM) EC50(pM)
Azinphos-ethyl 167.1 56.7 21.2 60.6 128.9
Phosalone 171.6 49.6 21.8 53.8 96.4
Coumaphos 173.6 46.7 21.8 52.6 26.9
phospholipids (33). Drugs including amit-
ryptyline, chlorpromazine, promethazine,
and propranolol have been shown to both
inhibit P-gp function (11) and cause excess
accumulation of phospholipids in tissues
(34). Thus, inhibition of P-gp by some
xenobiotics may result in phospholipid stor-
age disorders. Disruption ofanother murine
P-gp (mdrla gene product) compromises
the blood-brain barrier, resulting in
increased accumulation ofsome xenobiotics
in the brain (7). Accordingly, P-gp
inhibitors may potentiate the toxicity of
central nervous system toxicants.
Continuous exposure to some xenobiotics
results in decreased serum levels ofcorticos-
teroids (35). The inhibition of P-gp in the
adrenal gland by the xenobiotics could be
responsible for the reduced secretion ofcor-
ticosteroid by this organ. Clearly, much is to
be learned ofthe role ofP-gp in the elimina-
tion ofxenobiotics and as a target site for
xenobiotic toxicity. An understanding ofthe
characteristics that render xenobiotics as
transport substrates or inhibitory ligands of
P-gp will provide a foundation upon which
additional experimental evidence can be
generated to elucidate the role of this pro-
tein in chemical toxicityandelimination.
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